NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Contract Research Orgs » Tianjin Institute Of Pharmaceutical Research—Ne  1    
found files: 4
Tianjin Institute Of Pharmaceutical Research—Ne »01/10/2008 [Company watch]
Tianjin Pharma to trade on American Stock Exchange

TianyinPharmaceutical, Co., Inc., (OTC Bulletin Board: TYNP - News), a manufacturerand supplier of modernized traditional Chinese medicine ("TCM") based inChengdu, China, today announced that its common stock will begin trading onthe American Stock Exchange (the "AMEX") under the ticker "TPI" at market openon Wednesday, October 1, 2008. "Moving to the AMEX is a landmark for our Company. We expect that tradingon the AMEX will elevate our Company's standing within the internationalbusiness community, as well as our visibility among the investment community,"Dr. Jiang, Chairman and CEO of Tianyin commented. "I would like to thank bothTripoint Capital Advisors, the financial advisor for Tianyin Pharmaceuticals,and CMARK Capital, Tripoint's partner in China, for being instrumental withthe transition and activities since our Company became public." The AMEX Panel's approval is contingent upon the Company being in directcompliance with the Alternative Listing Standards at the time the Company'scommon shares begin trading on the AMEX, and may be rescinded if the Companyis not in compliance with such standards. Once Tianyin's common sharescommence trading on the AMEX, the Company will enjoy all of the sameprivileges and be subject to all of the same regulations as any other companywhose shares are listed on the AMEX, regardless of the Listing Standard usedto determine the Company's eligibility. Profile: Opening the gateway to China...   more»

Tianjin Institute Of Pharmaceutical Research—Ne »11/09/2009 [Company watch]
Four Tianyin products included in China\'s Essential Drug List

All the drugs in the Essential Drug List will be included in China\'s basic health insurance catalog with a higher reimbursement percentage....   more»

Tianjin Institute Of Pharmaceutical Research—Ne »18/09/2009 [Company watch]
Tianyin Pharma Granted GMP for New Solid Dose Facility

Tianyin Pharmaceutical announced it received GMP certification for its new solid dosage manufacturing facility from the SFDA. The company said the new facility will triple its solid dose capacity. Tianyin, which has historically concentrated in TCM, has been branching out into generic versions of western drugs....   more»

Tianjin Institute Of Pharmaceutical Research—Ne »28/09/2009
Tianyin Pharma reports 28.2% increase in sales in fiscal 2009

Tianyin Pharmaceutical Co., a developer, manufacturer and supplier of modernized traditional Chinese medicine (TCM) and generic pharmaceuticals in China, reported that for the fiscal year ended June 30, 2009, its revenues have increased 28.2% to $42.9 million from $33.5 million reported for the prior year period....   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.